دورية أكاديمية

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.

التفاصيل البيبلوغرافية
العنوان: The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
المؤلفون: Luzum, JA, Pakyz, RE, Elsey, AR, Haidar, CE, Peterson, JF, Whirl‐Carrillo, M, Handelman, SK, Palmer, K, Pulley, JM, Beller, M, Schildcrout, JS, Field, JR, Weitzel, KW, Cooper‐DeHoff, RM, Cavallari, LH, O'Donnell, PH, Altman, RB, Pereira, N, Ratain, MJ, Roden, DM
المصدر: Clinical Pharmacology & Therapeutics; Sep2017, Vol. 102 Issue 3, p502-510, 9p
مصطلحات موضوعية: PHARMACOGENOMICS, CLINICAL pharmacology, GUIDELINES, DRUG development, HEALTH programs, PUBLIC health
مصطلحات جغرافية: UNITED States
مستخلص: Numerous pharmacogenetic clinical guidelines and recommendations have been published, but barriers have hindered the clinical implementation of pharmacogenetics. The Translational Pharmacogenetics Program (TPP) of the National Institutes of Health (NIH) Pharmacogenomics Research Network was established in 2011 to catalog and contribute to the development of pharmacogenetic implementations at eight US healthcare systems, with the goal to disseminate real-world solutions for the barriers to clinical pharmacogenetic implementation. The TPP collected and normalized pharmacogenetic implementation metrics through June 2015, including gene-drug pairs implemented, interpretations of alleles and diplotypes, numbers of tests performed and actionable results, and workflow diagrams. TPP participant institutions developed diverse solutions to overcome many barriers, but the use of Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines provided some consistency among the institutions. The TPP also collected some pharmacogenetic implementation outcomes (scientific, educational, financial, and informatics), which may inform healthcare systems seeking to implement their own pharmacogenetic testing programs. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Pharmacology & Therapeutics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00099236
DOI:10.1002/cpt.630